Search results - 3 results
Monitoring HIV pre-exposure prophylaxis programmes in the EU/EEA
discussed briefly for each indicator. Users of the tool are encouraged to actively engage with the provided suggestions, and make adaptations where necessary. As such, this document does not set a normative ...
Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
diseases and risk factors and the monitoring of public health over time. Discussion Evidence on the disease burden in Belgium, expressed as DALY s, is available from international and national efforts. ...
Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting.
a selection of optimal responders based on biomarkers. In this paper we first discuss the legal framework for the development of valuable in vitro diagnostics. Based on a case study in lung cancer, the clinical ...